The EOI for human insulin now revised to include long-acting insulin analogues
The changes to the EOI for human insulin shown below in bold and italic
The changes to the EOI for human insulin shown below in bold and italic
The World Health Organization (WHO) is today confirming the suspension of supply of Covaxin produced by Bharat, through UN procurement agencies and recommending to countries that received the vacci
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Nirmatrelvir 150mg tablets + ritonavir 100mg tablets invited for COVID-19.
See full report:
A nitrosamine impurity, 1-methyl-4-nitrosopiperazine (MeNP), was identified in rifampicin products.
A 1st Invitation to Manufacturers of therapeutics against Ebola Virus Disease to submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit is being published by